debrisoquin has been researched along with isoproterenol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Cavero, I; Gerold, M; Haeusler, G; Saner, A | 1 |
| Beretta-Piccoli, C; Jahn, H; Schohn, D; Weidmann, P | 1 |
| Bryan-Lluka, LJ; Seers, H; Sharpe, I | 1 |
5 other study(ies) available for debrisoquin and isoproterenol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The cardiovascular effects of the antihypertensive drug debrisoquin: a contribution to the pharmacology of chronic treatment. I. One-week administration to dogs.
Topics: Animals; Debrisoquin; Dogs; Electric Stimulation; Female; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Isoproterenol; Isoquinolines; Male; Norepinephrine; Parasympathetic Nervous System; Perfusion; Pressure; Sympathetic Nervous System | 1978 |
Norepinephrine-related mechanism in hypertension accompanying renal failure.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Blood Volume; Debrisoquin; Female; Heart Rate; Humans; Hypertension; Isoproterenol; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Dialysis | 1985 |
Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
Topics: Animals; Binding, Competitive; Biological Transport, Active; Carrier Proteins; Catechol O-Methyltransferase Inhibitors; Catecholamine Plasma Membrane Transport Proteins; Debrisoquin; Endothelium, Vascular; Heart; Isoproterenol; Isotope Labeling; Lung; Male; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Myocardium; Neurons; Norepinephrine; Perfusion; Pyridazines; Rats; Rats, Wistar; Specific Pathogen-Free Organisms | 1996 |